<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE rss [<!ENTITY % HTMLlat1 PUBLIC "-//W3C//ENTITIES Latin 1 for XHTML//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml-lat1.ent">]>
<rss version="2.0" xml:base="http://www.healthedia.com">
<channel>
 <title>Blog Articles Tagged with &#039;avonex&#039; at http://www.healthedia.com</title>
 <link>http://www.healthedia.com/tags/avonex</link>
 <description>Blog Articles Tagged with &#039;avonex&#039; at http://www.healthedia.com</description>
 <language>en</language>
<item>
 <title>Understanding biologics: How they differ from drugs and why they cost more</title>
 <link>http://www.healthedia.com/sectors/directory/dr-zs-medical-report/924908?rsstype=tag&amp;tag=avonex</link>
 <description>Many of our readers either already have or will in the future encounter the possibility of being treated with a biologic medication.  This is because biologics have revolutionized the treatment of such chronic illnesses as rheumatoid arthritis, psori...</description>
 <guid>http://www.healthedia.com/sectors/directory/dr-zs-medical-report/924908?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Tue, 02 Dec 2008 12:43:24 -0500</pubDate>
</item>
<item>
 <title>Biogen Gets Cheaper Amid Doubts on Deal</title>
 <link>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/875158?rsstype=tag&amp;tag=avonex</link>
 <description>For a company trying to sell itself, Biogen   s shares sure have been sagging. Yesterday, they stood at $70.83 in 4 pm trading, a 14% drop from their price of $82.51 on Oct. 15, just after the company said it was on the block.Investors seem concerned...</description>
 <guid>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/875158?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Wed, 14 Nov 2007 10:14:56 -0500</pubDate>
</item>
<item>
 <title>Bidding About to Begin for Biogen</title>
 <link>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/874171?rsstype=tag&amp;tag=avonex</link>
 <description>Will cool heads or a bidding war emerge for Biogen Idec? With bids due next week, the Financial Times    dealReporter says that Pfizer, Merck and Johnson &amp; Johnson are likely to be among the  frontrunners among Big Pharma eager to bulk up in biotech....</description>
 <guid>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/874171?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Thu, 08 Nov 2007 10:14:16 -0500</pubDate>
</item>
<item>
 <title>Is Biogen Idec Overrated as Takeover Bait?</title>
 <link>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/872452?rsstype=tag&amp;tag=avonex</link>
 <description>Biogen Idec   s been the biotech flavor of the month ever since it said it was for sale. Speculation has put Pfizer, hungry for new products and a bigger presence in biotech, at the top of the list to buy Biogen. But the company   s stock has come of...</description>
 <guid>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/872452?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Mon, 29 Oct 2007 10:12:59 -0400</pubDate>
</item>
<item>
 <title>Pfizer and Biogen: Been There; Didn   t Do That</title>
 <link>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/870196?rsstype=tag&amp;tag=avonex</link>
 <description>As the reign of Pfizer CEO Hank McKinnell was entering its twilight almost two years ago, he fired off a short, internal email asking whether it was time to buy Biogen Idec, the Health Blog has learned. The answer to the query from McKinnell (picture...</description>
 <guid>http://www.healthedia.com/sectors/directory/wsjcom-health-blog/870196?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Mon, 15 Oct 2007 16:25:13 -0400</pubDate>
</item>
<item>
 <title>Paying pharma companies for results</title>
 <link>http://www.healthedia.com/sectors/directory/cancer-blog/854063?rsstype=tag&amp;tag=avonex</link>
 <description>Filed under: Drug, All CancersThe New York Times recently profiled pay-for-performance and risk-sharing pricing arrangements for high-cost drugs, including cancer drugs.For example, Johnson &amp; Johnson has proposed that the NHS in Britain pay for the c...</description>
 <guid>http://www.healthedia.com/sectors/directory/cancer-blog/854063?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Tue, 17 Jul 2007 07:00:00 -0400</pubDate>
</item>
<item>
 <title>MS of the nervous system</title>
 <link>http://www.healthedia.com/sectors/directory/mri-links-and-other-cool-things/829547?rsstype=tag&amp;tag=avonex</link>
 <description>Multiple sclerosis (MS) is one of the most common diseases of the central nervous system. Today over 2,500,000 people around the world have MS.MS is the result of damage to myelin - a protective sheath surrounding nerve fibres of the central nervous ...</description>
 <guid>http://www.healthedia.com/sectors/directory/mri-links-and-other-cool-things/829547?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Thu, 08 Mar 2007 09:00:00 -0500</pubDate>
</item>
<item>
 <title>Transgenic Chickens Manufacture Expensive Drugs</title>
 <link>http://www.healthedia.com/sectors/directory/healthcare-nbic/829585?rsstype=tag&amp;tag=avonex</link>
 <description>Here&#039;s a follow-up to our popular post about transgenic pigs makingdrugs in their milk. Oxford Biomedica and Viragen, Inc. yesterday announced that they have produced two therapeutic proteins in the whites of transgenic chicken eggs. Publishing in th...</description>
 <guid>http://www.healthedia.com/sectors/directory/healthcare-nbic/829585?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Tue, 16 Jan 2007 14:20:16 -0500</pubDate>
</item>
<item>
 <title>Transgenic Chickens Manufacture Expensive Drugs</title>
 <link>http://www.healthedia.com/sectors/directory/healthcare-nbic/844341?rsstype=tag&amp;tag=avonex</link>
 <description>Here&#039;s a follow-up to our popular post about transgenic pigs makingdrugs in their milk. Oxford Biomedica and Viragen, Inc. yesterday announced that they have produced two therapeutic proteins in the whites of transgenic chicken eggs. Publishing in th...</description>
 <guid>http://www.healthedia.com/sectors/directory/healthcare-nbic/844341?rsstype=tag&amp;tag=avonex</guid>
 <pubDate>Tue, 16 Jan 2007 14:20:16 -0500</pubDate>
</item>
</channel>
</rss>
